Who is Eligible for the Shingles Vaccine?
According to the Centers for Disease Control and Prevention (CDC), all healthy adults aged 50 and older should receive the recombinant zoster vaccine (RZV), known as Shingrix. This includes 65-year-olds. The CDC recommends a two-dose series even if you've had chickenpox or the older Zostavax vaccine, which is no longer available in the U.S. The risk of shingles and complications like postherpetic neuralgia increases with age.
Why Shingrix is the Recommended Vaccine
Shingrix is preferred due to its high effectiveness, over 90% in healthy adults over 50, and 91% for those 70 and older, offering better protection than Zostavax. This is especially important for seniors with naturally weakening immune systems.
The Shingrix Vaccination Process
Shingrix is a two-dose vaccine. The first dose is an injection in the upper arm. The second dose is given 2 to 6 months later. Completing both doses is essential for maximum protection.
Potential Side Effects
Temporary side effects, lasting 2 to 3 days, are common and indicate the immune system is responding. For more information, visit {Link: Shingrix.com https://www.shingrix.com/side-effects/}.
Cost and Coverage for Seniors
Cost is a concern, but many insurance plans, including Medicare, cover the vaccine.
Medicare Coverage for Shingrix
Shingrix is covered under Medicare Part D, and there are generally no out-of-pocket costs for ACIP-recommended adult vaccines like Shingrix due to the Inflation Reduction Act. Medicare Advantage plans also often cover the vaccine with no cost to the beneficiary.
Private Health Insurance
Most private plans also cover the vaccine. Confirm coverage with your provider.
Shingrix vs. Zostavax: A Comparative Look
Zostavax is discontinued.
| Feature | Shingrix (RZV) | Zostavax (Discontinued) |
|---|---|---|
| Vaccine Type | Recombinant (non-live) | Live Attenuated |
| Doses Required | 2 doses, 2–6 months apart | 1 dose |
| Efficacy | >90% in healthy adults over 50 | Waning effectiveness over time |
| Protection from PHN | >90% effective | ~67% effective initially |
| Immunity | Durable, long-lasting | Wanes after about 5 years |
| Recommendation | Recommended for all eligible adults | Discontinued in the U.S. in 2020 |
Why Vaccination is Crucial for Older Adults
Older adults face higher risks of severe shingles complications: Postherpetic Neuralgia (PHN), Vision Loss, and potential increased risk of Stroke and Heart Attack. The benefits of vaccination outweigh the minor side effects. Shingrix offers crucial protection for healthy aging. For more information, visit the official {Link: CDC website https://www.cdc.gov/shingles/vaccines/index.html}.
Conclusion: Taking Control of Your Health at 65+
Being 65 makes you eligible for the shingles vaccine, as recommended by the CDC. The two-dose Shingrix vaccine provides strong protection against shingles and its complications. With good insurance coverage options like Medicare, getting vaccinated is accessible. Discuss vaccination with your healthcare provider or pharmacist.